HCT Regenerative is the first company in Taiwan to focus on processing human tissue to provide orthobiologics and regenerative biomaterials for clinical use.
Our mission is to develop advanced human cellular and tissue based products (HCT/Ps) to improve patients' quality of life.
We are the first and only known company in Asia to process and bank human amniotic tissue, rich in growth factors and cytokines, and provide it for clinical use.
The products we develop and manufacture can be utilized in orthopedics, neurosurgery, sports medicine, ophthalmology, plastic surgery, wound management, dental, and cosmetics.
HCT Regenerative is approved by the TFDA and we are the only establishment in Taiwan to be accredited by the American Association of Tissue Banks (AATB).
Our management team has years of experience and extensive connections both in Taiwan and in the United States to the tissue banking and healthcare community.
Learn more about HCT Regenerative's quality assurance process.
...to develop and manufacture advanced human cellular tissue based products (HCT/Ps) to improve patients' quality of life.
...to become the largest tissue processor in Asia, working with global device companies to meet their patients' needs.
Managing Director and Co-founder
James is the Managing Director and a co-founder of HCT Regenerative. James previously worked as the Research and Development Director at LifeLink Tissue Bank for 8 years. He has also served as a member of the scientific and development committee of the AATB, both in biology and applied medicine. James has experience in the development of tissue products, knowledge of tissue processing technology and other key technical knowledge.
Chair and Co-founder
Leslie serves as the chair of the board and is a co-founder of HCT Regenerative. Leslie has a background in drug development and clinical experience. She served with the Taiwanese department of health and is licensed to practice pharmacy in both Taiwan and the United States.
Board of Director and Co-founder
Dana serves on the board of directors and is a co-founder of HCT Regenerative. Dana is the grandson of Dr. Dana Shires Jr., who founded LifeLink Foundation, a non-profit organ procurement organization based in Florida. His father, Dana Shires III, served as LifeLink Tissue Bank’s Executive Director for nearly three decades.